Frequency of remission in schizophrenia patients at one year follow-up;Remissionshäufigkeit bei schizophren erkrankten patienten innerhalb eines jahres nach der klinikentlassung

Psychiatrische Praxis

Volumn 36, Issue 4, 2009, Pages 182-188

  Zimmermann, Jörg ^a,d   Wolter, Arne ^a,c   Hannöver, Wolfgang ^b   Krischke, Norbert ^c  

^a Krankenhaus Bethanien   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c UNIVERSITY OF OLDENBURG   (Germany)

^d Karl Jaspers Klinik   (United States)

Author keywords

Follow up; Naturalistic study; Quality management; Remission; Schizophrenia

Indexed keywords

ARTICLE; FOLLOW UP; GERMANY; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; REMISSION; SCHIZOPHRENIA; ADULT; FEMALE; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; KAPLAN MEIER METHOD; MALE; MENTAL HOSPITAL; MIDDLE AGED; OUTCOME ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; RECURRENT DISEASE; STANDARD; STATISTICS; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UTILIZATION REVIEW;

ADULT; FEMALE; FOLLOW-UP STUDIES; GERMANY; HOSPITALS, PSYCHIATRIC; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PATIENT READMISSION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY ASSURANCE, HEALTH CARE; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

EID: 68049085631     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0028-1090035     Document Type: Article

References (36)

1. Leucht S, Beitinger R, Kissling W. On the concept of remission in schizophrenia. Psychopharmacol 2007; 194 (4): 453-461
2. Andreasen NC, Carpenter WT Jr, Kane JM et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162 (3): 441-449 (Pubitemid 40343909)
3. Van Os J, Drukker M, à Campo J et al. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006; 163 (11): 2000-2002
4. Buckley PF, Harvey PD, Bowie CR et al. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schiz Res 2007; 94 (1-3): 99-106
5. De Hert M, van Winkel R, Wampers M et al. Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort. Schiz Res 2007; 92 (1-3): 68-73 (Pubitemid 46561226)
6. Docherty JP, Bossie CA, Lachaux B et al. Patient-based and clinician-based support for the remission criteria in schizophrenia. Int J Clin Psychopharmacol 2007; 22 (1): 51-55 (Pubitemid 44950768)
7. Lasser A, Bossie A, Gharabawi M et al. Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection. Schiz Res 2005; 77 (2-3): 215-227
8. Dunayevich E, Sethuraman G, Enerson M et al. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes. Schizophr Res 2006; 86 (1-3): 300-308 (Pubitemid 44234057)
9. Haro JM, Novick D, Suarez D et al. Remission and relapse in the outpatient care of schizophrenia - three-year results from the Schizophrenia Outpatient Health Outcomes Study. J Cl Psychopharmacol 2006; 26 (6): 571-578 (Pubitemid 44772733)
10. Helldin L, Kane JM, Karilampi U et al. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 2006; 40 (8): 738-745 (Pubitemid 44486248)
11. Jäger M, Riedel M, Schmauss M et al. Prediction of symptom remission in schizophrenia during inpatient treatment. World J Biol Psychiatry 2007 (online) DOI: 10.1080/15622970701541054
12. Kane JM, Crandall DT, Marcus RN et al. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schiz Res 2007; 95 (1-3): 143-150 (Pubitemid 47313629)
13. Lambert M, Schimmelmann BG, Naber D et al. Prediction of remission as a combination of symptomatic remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006; 67 (11): 1690-1697 (Pubitemid 44955148)
14. Lambert M, Naber D, Eich FX et al. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 2007; 115 (2): 106-113 (Pubitemid 46114871)
15. Novick D, Haro JM, Suarez D et al. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study. Psychopharmacol 2007; 191 (4): 1015-1022 (Pubitemid 46399150)
16. Opler MG, Yang LH, Caleo S et al. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings. BMC Psychiatry 2007; 24, 7 (1): 35 (Pubitemid 47308268)
17. San L, Ciudad A, Alvarez E et al. Symptomatic remission and social /vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry 2007; 22 (8): 490-498 (Pubitemid 350087651)
18. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999; 156 (1): 5-10 (Pubitemid 29034873)
19. Haro JM, Edgell ET, Jones PB et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment. Acta Psychiatr Scand 2003; 107 (3): 222-232 (Pubitemid 36250283)
20. Gilbody S, Wahlbeck K, Adams C. Randomized controlled trials in schizophrenia: a critical perspective on the literature. Acta Psychiatr Scand 2002; 105 (4): 243-251 (Pubitemid 34275840)
21. Kallert TW. Braucht psychiatrische Versorgungsforschung randomisierte kontrollierte Studien? Psychiat Prax 2005; 32 (8): 375-377
22. Hofer A, Hummer M, Huber R et al. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000; 20 (6): 699-702 (Pubitemid 30953813)
23. Riedel M, Strassnig M, Müller N et al. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? Eur Arch Psych Clin Neur 2005; 255 (2): 143-158
24. Roder V, Brenner HD, Kienzle N et al. Integriertes Psychologisches Therapieprogramm für schizophrene Patienten (IPT). Weinheim: Psychologie Verlags Union, 1992
25. Berger H, Friedrich J, Gunia H. Psychoedukative Familienintervention: Manual zu Grundlagen und Praxis. Stuttgart: Schattauer, 2004
26. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812
27. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Brit J Psych 1989; 7 (Suppl): S59-S67
28. th ed. Washington, DC: American Psychiatric Press, 1996
29. Naber D. Subjektives Wohlbefinden unter Neuroleptika (Lang- und Kurzform). In: Schumacher J, Klaiberg A, Brähler E, Hrsg. Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. Göttingen: Hogrefe, 2003
30. Cording C, Gaebel W, Sprengler A et al. Die neue psychiatrische Basis-dokumentation. Eine Empfehlung der DGPPN zur Qualitätssicherung im (teil-)stationären Bereich. Spektrum der Psychiatrie, Psychotherapie und Nervenheilkunde 1995; 24: 3-41
31. Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale: Lawrence Erlbaum Associates, 1988
32. Hedges LV, Hasselblad V. Meta-analysis of screening diagnostic tests. Psychol Bull 1995; 117 (1): 167-178
33. Höer A, Gothe H, Seidlitz C et al. Prädiktoren für die Rehospitalisierung bei Patienten mit Schizophrenie. Nervenarzt 2006; 77 (Suppl. 3): S135
34. Roick C, Gärtner A, Heider D et al. Heavy user psychiatrischer Versorgungsdienste. Ein Überblick über den Stand der Forschung. Psychiat Prax 2002; 29 (7): 334-342
35. Zimmermann J, Wolter A, Krischke N. Verbesserung der Schnittstellenproblematik durch ein poststationäres psychoedukativ- orientiertes Gruppenangebot bei schizophrenen Patienten. Zeitschrift für Gemeindenahe Psychiatrie 2008; 2: 47-59
36. Karow A, Moritz S, Lambert M et al. PANSS syndromes and quality of life in schizophrenia. Psychopathology 2005; 38 (6): 320-326 (Pubitemid 43074271)